Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
09/11/2002 | EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3 |
09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
09/11/2002 | EP1237562A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
09/11/2002 | EP1237403A1 Method of usinf mapk4 and orthologues thereof to control plant disease and plantgrowth |
09/11/2002 | EP1178113A9 Plant protein with pyrroline-5-carboxylat-dehydrogenase activity |
09/11/2002 | EP1173459A4 Codeinone reductase from alkaloid poppy |
09/11/2002 | EP1165881B1 Multi-component system for the enzyme-catalysed oxidation of substrates and method for carrying out enzyme-catalysed oxidation |
09/11/2002 | EP1141507A4 Hinge structure |
09/11/2002 | EP0870053A4 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
09/11/2002 | EP0865241B1 Use of a deaminating oxidase in baking |
09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
09/11/2002 | EP0708835B1 Fruit specific promoters |
09/11/2002 | CN1369016A Novel means of transformation of fungi and their use for heterologous protein production |
09/11/2002 | CN1369014A Production of proteins |
09/11/2002 | CN1369013A Monocellular or multicellular organisms for production of riboflavin |
09/11/2002 | CN1369012A Delta 6-acetylenase and delta-6 desaturase from ceratodon purpureus |
09/11/2002 | CN1369008A Intramolecularly cross-linked substilisin proteases having reduced immunonicity |
09/11/2002 | CN1369007A Alkaline xyloglucanase from malbranchea |
09/11/2002 | CN1368888A Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disaese |
09/11/2002 | CN1368843A Transgenic animals expressing salivary proteins |
09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
09/11/2002 | CN1090675C Method for hydrolysing proteins |
09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
09/10/2002 | US6448476 Plants and plant cells transformation to express an AMPA-N-acetyltransferase |
09/10/2002 | US6448475 Transgenic plants can be made that have altered tocopherol levels in their tissues for increased vitamin e supplementation |
09/10/2002 | US6448474 Transforming a coffee plant with a vector comprising a nucleic acid sequence from a coffee fruit that codes for an rna that is sense/antisense to a coffee fruit-expressed mrna for acc oxidase; applying ethylene to fruit to ripen |
09/10/2002 | US6448472 Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the conference of hormone and herbicide resistance |
09/10/2002 | US6448388 Polynucleotides encoding proteins sharing sequence similarity with mammalian proteases; proteases are associated with inter alia, regulating development, diabetes, obesity, infertility, modulating cellular processes, and infectious disease |
09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
09/10/2002 | US6448272 Myt1 kinase inhibitors |
09/10/2002 | US6448224 Antibiotics and methods of using the same |
09/10/2002 | US6448093 Solubilization of hyaluronic acid in aqueous solution of electrolyte and acid; solubilization of polar substancec (i.e. a plasmid) in mixture; acidification; dialyzing said mixture to reduce an ionic concentration past point of collapse |
09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
09/10/2002 | US6448059 Methods and composition for inhibition of tRNA activities |
09/10/2002 | US6448058 Method of inhibiting a peptide deformylase, the method comprising contacting the peptide deformylase with one or more compounds of the invention |
09/10/2002 | US6448057 Use in the development of human therapeutics and disease diagnosis |
09/10/2002 | US6448056 Microbial xyloglucan endotransglycosylase (XET) |
09/10/2002 | US6448055 Δ9-desaturase gene |
09/10/2002 | US6448052 To convert ethyl 4-chloroacetoacetate using nadph as a coenzyme to produce ethyl (s)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal ph and temperature; enzyme from candida |
09/10/2002 | US6448049 Starch conversion process |
09/10/2002 | US6448046 Possessing enhanced stability within a host, enabling the sustained systemic transcription of a nucleotide sequence; accomplished by the use of a dual subgenomic promoter system which reduces the frequency of recombination |
09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
09/10/2002 | US6448038 BirA from staphylococcus aureus |
09/10/2002 | US6448037 PgsA |
09/10/2002 | US6448036 ribB |
09/10/2002 | US6448033 Incubating a sample of ribosomes obtained from a cell-free extract with plasmid dna containing a coding sequence for a protein of interest with an aminoacyl trna having fluorescent label |
09/10/2002 | US6448026 Measuring changes in microtubule stimulated atpase activity as indication of modulatory activity of candidate on target protein |
09/10/2002 | US6448025 Motor proteins and methods for their use |
09/10/2002 | US6447811 Pesticide against plant-pathogenic microorganisms |
09/10/2002 | US6447773 Member of ATP dependent protease family, clpL |
09/10/2002 | US6447772 Compositions and methods relating to reduction of symptoms of autism |
09/10/2002 | US6447771 Methods and materials relating to novel CD39-like polypeptides |
09/10/2002 | US6447768 Methods of gene therapy with a DNA sequence encoding NOS |
09/10/2002 | CA2234876C Positive selection vector for bacillus sp. |
09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
09/10/2002 | CA2128247C Vaccines based on streptokinase |
09/10/2002 | CA2079442C A process using cellulase for improving drainage properties of pulp |
09/06/2002 | WO2002069232A2 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
09/06/2002 | WO2002069198A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
09/06/2002 | WO2002068933A2 Small molecule design against drug resistant mutants using directed evolution |
09/06/2002 | WO2002068694A1 Differentially methylated sequences in pancreatic cancer |
09/06/2002 | WO2002068692A1 Methods for improving or altering promoter/enhancer properties |
09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
09/06/2002 | WO2002068671A1 Method of deamidation of milk protein and method of denaturation of milk protein |
09/06/2002 | WO2002068666A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
09/06/2002 | WO2002068665A2 Constitutive promoter from arabidopsis |
09/06/2002 | WO2002068661A1 FUSED PROTEIN HAVING β1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE II ACTIVITY AND PROCESS FOR PRODUCING THE SAME |
09/06/2002 | WO2002068659A1 Agarase and gene thereof |
09/06/2002 | WO2002068658A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
09/06/2002 | WO2002068657A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
09/06/2002 | WO2002068656A1 Nucleic acids coding for a protein interacting with a porin channel |
09/06/2002 | WO2002068643A1 Nomuraeae rileyi-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
09/06/2002 | WO2002068623A2 Genes encoding proteolytic enzymes from aspargilli |
09/06/2002 | WO2002068622A2 Crystal structure information of pnp synthase and the use thereof |
09/06/2002 | WO2002068620A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
09/06/2002 | WO2002068619A2 Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use |
09/06/2002 | WO2002068618A1 Methods for monitoring protease inhibitor antiretroviral therapy |
09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/06/2002 | WO2002068616A2 Tissue transglutaminase |
09/06/2002 | WO2002068613A1 Biosynthesis of polyketide synthase substrates |
09/06/2002 | WO2002068607A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
09/06/2002 | WO2002068599A2 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
09/06/2002 | WO2002068598A2 Novel selectable marker in plants and other organisms |
09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
09/06/2002 | WO2002068595A2 Mono-and diacylglycerol acyltransferases and methods of use thereof |
09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
09/06/2002 | WO2002068575A1 Liquid detergent composition exhibiting enhanced α-amylase enzyme stability |
09/06/2002 | WO2002068473A1 Biosensor for detecting chemical agents |
09/06/2002 | WO2002068464A2 Fusion protein for blocking the hiv nef protein |
09/06/2002 | WO2002068462A2 Internal standard for electrophoretic and chromatographic separation processes |
09/06/2002 | WO2002068458A2 Disintegrin homolog, zsnk16 |
09/06/2002 | WO2002068454A2 Proteins in a porous support |
09/06/2002 | WO2002068448A1 Method for evaluating the ability to metabolize pharmaceuticals and compositions therefor |
09/06/2002 | WO2002068444A1 Ttk in diagnosis and as a therapeutic target in cancer |
09/06/2002 | WO2002068436A1 Avilamycin derivatives |
09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |